MPG.eBooks - Search Results - "Sodium-glucose Transporter 2 Inhibitors / Therapeutic Use"

Search alternatives:
transporter 2 » transporter _
2 inhibitors » _ inhibitors

Cover Image

1

Sodium-glucose cotransporter 2 inhibitors for the treatment of diabetic nephropathy : a review of clinical effectiveness

by Banerjee, Srabani, Grobelna, Aleksandra
Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

2

Empagliflozin (Jardiance)

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

3

Empagliflozin (Jardiance)

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

4

Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Amanda, Shane, Butcher, Robyn
Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

5

Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

by Amanda, Shane, Butcher, Robyn
Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

6

Type 2 diabetes in adults management : evidence reviews for SGLT-2 inhibitors and GLP-1 mimetics

Published 2018

National Institute for Health and Care Excellence (UK)

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

7

CADTH CDEC final recommendation: Empagliflozin (Jardiance -- Boehringer Ingelheim (Canada) Ltd.) : indication : Type 2 Diabetes mellitus

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

8

Patient group input submissions: Empagliflozin and metformin (Synjardy) for diabetes mellitus (Type 2)

Published 2017

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

9

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

10

CADTH Canadian Drug Expert Committee final recommendation: Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) : indication : type 2 diabetes mel...

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

11

Clinical review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

12

Clinical review report: Ertugliflozin (Steglatro) (Merck Canada Inc.) : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

13

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

14

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin (Steglatro -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

15

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

16

Common drug review new combination product: Ertugliflozin/Metformin fixed-dose combination (Segluromet) Merck Canada Inc. : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

17

CADTH Canadian Drug Expert Committee recommendation: Ertugliflozin/Metformin (Segluromet -- Merck Canada Inc.) : indication : diabetes mellitus, type 2

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”

Cover Image

18

Common drug review new combination product: Ertugliflozin/Metformin fixed-dose combination (Segluromet) Merck Canada Inc. : indication : type 2 diabetes mellitus

Published 2019

CADTH

Subjects: “...Sodium-Glucose Transporter 2 Inhibitors / therapeutic use...”